Navigation Links
Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers'
Date:5/16/2008

NUTLEY, N.J., May 16 /PRNewswire/ -- Barbara Senich, B.S.N., M.B.A., M.P.H., Roche vice president, Sales and Marketing Services, was honored by Executive Women of New Jersey (EWNJ) at its "Salute to the Policy Makers" 2008 Awards Dinner. The biennial event, held May 15, 2008 at the Hyatt Regency New Brunswick, recognized women of professional distinction in New Jersey who are senior executives or members of boards of directors at major New Jersey-based corporations and organizations.

"Barbara is extremely deserving of this honor. As a member of Roche senior management, she participates in all areas of corporate decision making. Her knowledge, experience and leadership are instrumental in helping Roche build a world class organization that effectively serves the needs of the healthcare community as well as the patients whose lives are improved by our medicines," said George Abercrombie, president and CEO of Hoffmann-La Roche Inc.

"Over the course of the last two decades, the Salute to the Policy Makers Awards Dinner has evolved into a 'Hall of Fame' of sorts for accomplished women throughout the Garden State and we are pleased to include Barbara Senich among the 36 women honored this year," added EWNJ President-Elect and 2008 Salute Dinner Chair Mary S. Hartman, Ph.D., who also serves as director of the Institute for Women's Leadership at Rutgers University.

Senich, who joined Roche in 2004 in her current position, has extensive experience in the pharmaceutical industry, especially in the areas of managed care, pricing, market research and product marketing. She leads a multifunctional area of eight departments including the Transplant Therapeutic area, Account Management and others that provide critical strategic and analytical support to the company's commercial operations.

Senich began her career in the pharmaceutical industry as a sales representative and held a number of increasingly responsible marketing and sales positions before coming to Roche. She holds an M.B.A. from Columbia Business School and an M.P.H. from Columbia University. She earned a B.S. in Nursing from the University of North Carolina, and is a board member of the UNC-Chapel Hill School of Nursing Foundation. She also serves on the advisory committee of the Women Business Leaders of the U.S.

Proceeds from the Salute to the Policy Makers 2008 Awards Dinner are funding EWNJ's scholarship program, which has provided over $875,000 in scholarships to more than 275 deserving New Jersey women enrolled in advanced degree programs at N.J. institutions since 1986.

Public Service Enterprise Group (PSEG) Chairman of the Board, President and CEO Ralph Izzo served as honorary chair of the event, at which Gwen Ifill, Washington Week managing editor and senior correspondent for The News Hour with Jim Lehrer was guest speaker. Distinguished honorary chairpersons included N.J. Governor Jon Corzine, The Honorable Richard J. Codey, The Honorable Donald T. DiFrancesco, The Honorable Christine Todd Whitman, The Honorable James J. Florio, The Honorable Thomas H. Kean Sr., and The Honorable Brendan T. Byrne. Roche Public Affairs Vice President Carolyn Glynn is a past EWNJ honoree.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by Med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a Top Company for Older Workers (AARP) and one of the Best Companies to Work For in America (Fortune). For additional information about the U.S. pharmaceuticals business, visit our website http://www.rocheusa.com. Product and treatment information for U.S. healthcare professionals is available at http://www.RocheExchange.com.

All trademarks used or mentioned in this release are protected by law.

About Executive Women of New Jersey

Founded in 1980 as New Jersey's premier organization for senior level women, EWNJ promotes the advancement of women to the highest levels of business, the professions and government. EWNJ also assists corporations seeking qualified candidates for board of director positions. EWNJ awards approximately $60,000 annually to 20 New Jersey women pursuing advanced degrees. For more information on corporate sponsorship or the Salute to the Policy Makers awards dinner, contact EWNJ at 609-249-7982 or visit http://www.ewnj.org.

Contact(s): Public Affairs

(973) 562-2699


'/>"/>
SOURCE Roche Public Affairs
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Roche Symposium Showcases Accomplishments of Next Generation of Chemists
2. Roches Vidal Honored as 2008 HBA Rising Star
3. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
4. Media advisory - Neurochems Annual and Special Meeting of Shareholders April 15, 2008
5. Neurochem Annual and Special Meeting of shareholders
6. Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters
7. Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis
8. Roche Statement Regarding Tamiflu U.S. Label Revision
9. Neurochem announces departure of two members of management team
10. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
11. Press Statement: Roche Affirms That Tamiflu(R) is in Ample Supply Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... ... Will Never Be The Same” is a fictional tale about growing up with the ... the creation of published author, Kim T. Briggs, a self-described “big kid” who has ... and philosophy from Judson University in Elgin, Illinois. Having written numerous Christian drama skits ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... ability of physical therapist assistants, under direct supervision of a licensed physical therapist, ... physical therapy receives a consultation and treatment plan from a licensed physical therapist ...
(Date:12/5/2016)... IL (PRWEB) , ... December 05, 2016 , ... The ... to the individual looking to buy neoprene knee sleeves for lifting and ... The design focuses heavily on two main aspects to provide a higher quality knee ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... an excellent way to ensure moisture measurements are consistently correct. However, regular ... , Now, METTLER TOLEDO offers a solution: SmartCal™ . This ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... they have teamed up with The American College of Surgeons (ACS) to provide ... on Trauma, the “Bleeding Control Basic” course is a pilot program that fulfills ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 ... today announced preliminary safety and efficacy data from ... oral selective MDM2 inhibitor, suggesting that DS-3032 may ... relapsed/refractory acute myeloid leukemia (AML) and high-risk myelodysplastic ... part of the phase 1 study of DS-3032 were ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. announced ... the 2016 Annual Meeting of the American Epilepsy Society ... is indicated as an adjunctive therapy for the treatment ... generalized seizures and primary generalized tonic-clonic seizures (PGTC) in ... and older. Please see Important Safety Information for FYCOMPA, ...
(Date:12/5/2016)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... candidates, presents positive Phase 2a correlative data, as well as ... at the ongoing 58th American Society of Hematology (ASH) Annual ... . ... As previously announced, in ...
Breaking Medicine Technology: